Patent litigation could explode in the wake of the Supreme Court's rulingThis is great news! I hope to see a lot more bogus patents being challenged.
Tuesday in a closely watched dispute over patent validity between two
The Court, by an 8-1 vote, reinstated a lawsuit by MedImmune challenging a
Genentech patent related to Synagis, a popular drug for treatment of respiratory
disease in children. The opinion in MedImmune v. Genentech, written by
Justice Antonin Scalia, says patent licensees no longer have to breach the
license in order to have standing to challenge the patent that they dispute.
Patent lawyers say the ruling could lead to a flurry of challenges to existing
High Court Ruling Could Spark Surge in Patent Challenges